U.S Class(es): 006, 018, 044, 046, 051, 052
| Name | Novartis Pharma AG, Trademark Department |
|---|---|
| Address | Postfach CH-4002 Basel, SWITZERLAND |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Sep-20-2018 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM | |
| Sep-25-2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
| Sep-26-2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Sep-28-2018 | ASSIGNED TO EXAMINER | DOCKD | |
| Sep-28-2018 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
| Oct-02-2018 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
| Oct-24-2018 | NOTICE OF PUBLICATION | NPUBO | |
| Nov-07-2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
| Nov-07-2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
| Nov-13-2018 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Nov-30-2018 | NOTIFICATION PROCESSED BY IB | GPNXP | |
| Jan-29-2019 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
| Feb-28-2019 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
| Mar-13-2019 | FINAL DISPOSITION PROCESSED | FIMPP | |
| Mar-13-2019 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
| Jul-26-2019 | NOTIFICATION PROCESSED BY IB | GPNXP | |
| Aug-15-2025 | CANCELLED SECTION 71 | C71TO |